2024-07-15 NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024 | CE WHAT'S TRENDING ON JNCCN.ORG NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024 | CE Outcomes in Nonmetastatic Hormone Receptor–Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study 回上一頁
